LinkZill Nets Tens of Millions of CNY in pre-Series A+
Hangzhou LinkZill (Chinese: 杭州领挚科技有限公司) recently announced its completion of a pre-Series A+ financing round worth tens of millions of CNY led by Apricor capital (Chinese: 杏泽资本), with participation from Zhen Fund (Chinese: 真格基金). The proceeds will be used for continuous promotion of the application of TFT semiconductor chips in the field of life sciences.
Established in 2019, with thin film transistor semiconductor chips as its core products and technologies, LinkZill focuses on the industrial applications of them in life sciences, sensor display and other fields. LinkZill has served hundreds of global technology companies, universities and research institutes through its core TFT chip technology, and has accumulated comprehensive three-dimensional technical capabilities.
Briefing Jan 31, 2023 11:02 AM
· Healthcare
Fine Vision Completes Angel Financing Round Worth Nearly CNY 50 Mn
Briefing Jan 28, 2023 11:20 AM
· Healthcare
YingHe Neuro Raises Over CNY 100 Mn in Angel Round
In-depth
Healthcare
Tsingke Biotechnology: More Opportunities in the International Market of Gene Synthesis
‘Globalization is the only way to the development of the industry. It is more conducive to the rapid progress of the industry for domestic enterprises to compete with well-known overseas enterprises.’
Jan 30, 2023 02:13 PM
Briefing Jan 13, 2023 11:03 AM
· Healthcare
Equipment Company Keyto Nets Over CNY 100 Mn in Series C
Briefing Jan 12, 2023 10:25 AM
· Healthcare
Surgical Robot Platform Company KouTech Nets Over USD 10 Mn in Series A+ Round
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Research
Consumer Staples, Healthcare, TechnologyWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Briefing Sep 09, 2022 04:12 PM
· Healthcare
Trulive Nets Hundreds of Mns of CNY in pre-Series B Financing Round
Briefing Jun 24, 2022 11:15 AM
· Healthcare
F-star to be acquired by China biopharmaceutical with USD 161million
Briefing Jun 24, 2022 11:07 AM
· Healthcare
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
Insight
Briefing Jun 24, 2022 10:46 AM
· Healthcare
East China medicine "liraglutide" goes to sea
Briefing Jun 23, 2022 06:25 PM
· Healthcare
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Briefing Jun 23, 2022 06:24 PM
· Healthcare
Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing
Insight
Healthcare
Opportunities and Challenges Hidden in the CGT Industry in China
CGT (Cell and Gene Therapy) is a sector with high growth potential. CAR-T, as one of the main CGT currently, presents great value for both doctors and patients. This article showcases the industry pain points and opportunities faced in the CAR-T sub-sector.
Jan 17, 2023 05:48 PM
Briefing Jun 23, 2022 10:36 AM
· Healthcare
Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China
Briefing Jun 23, 2022 10:27 AM
· Healthcare
Yanye new crown drug 3CL protein inhibitor has been suspended approval
Briefing Jun 23, 2022 10:24 AM
· Healthcare
Sanofi Greater China will be headed by Shi Wang, and Henting he will become the global head of the digital business unit
Briefing Jun 23, 2022 10:22 AM
· Healthcare
Acadia Alzheimer's drug SNDA application rejected by FDA advisory committee
See more
Read next
Insight
In-depth
Insight
In-depth
Consumer Discretionary
GeerTop: China's Camping Market Growth Expected to Slow
Feb 02, 2023 12:01 PM
Insight
In-depth
Healthcare
Chinese Company Turned the Tables on Domestic Cell Culture Media Market
Feb 02, 2023 10:45 AM
Insight
In-depth